TRACON Pharmaceuticals Inc
OTC:TCON
TRACON Pharmaceuticals Inc
OTC:TCON
Price:
0.0322
USD
Market Closed
Market Cap:
$109.8k
Balance Sheet
Balance Sheet Decomposition
TRACON Pharmaceuticals Inc
TRACON Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
TRACON Pharmaceuticals Inc
TRACON Pharmaceuticals Inc
Balance Sheet
TRACON Pharmaceuticals Inc
TRACON Pharmaceuticals Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
35
|
41
|
36
|
29
|
25
|
16
|
32
|
24
|
17
|
9
|
|
| Cash Equivalents |
35
|
41
|
36
|
29
|
25
|
16
|
32
|
24
|
17
|
9
|
|
| Short-Term Investments |
0
|
11
|
9
|
5
|
14
|
0
|
4
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
36
|
53
|
46
|
36
|
41
|
17
|
37
|
25
|
18
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
38
N/A
|
54
+40%
|
46
-15%
|
36
-21%
|
41
+13%
|
18
-55%
|
37
+107%
|
27
-29%
|
19
-27%
|
10
-48%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
8
|
6
|
7
|
11
|
8
|
2
|
5
|
4
|
3
|
|
| Accrued Liabilities |
0
|
1
|
2
|
1
|
1
|
2
|
6
|
7
|
9
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
1
|
0
|
3
|
1
|
3
|
3
|
1
|
10
|
0
|
|
| Other Current Liabilities |
5
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
13
|
14
|
10
|
12
|
13
|
12
|
11
|
14
|
22
|
10
|
|
| Long-Term Debt |
4
|
7
|
7
|
5
|
5
|
3
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
1
|
0
|
3
|
0
|
1
|
0
|
1
|
4
|
1
|
|
| Total Liabilities |
20
N/A
|
23
+10%
|
17
-23%
|
19
+10%
|
19
+0%
|
15
-20%
|
12
-20%
|
15
+20%
|
27
+79%
|
11
-59%
|
|
| Equity | |||||||||||
| Common Stock |
50
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
34
|
59
|
86
|
105
|
140
|
162
|
179
|
208
|
237
|
240
|
|
| Additional Paid In Capital |
2
|
90
|
114
|
122
|
161
|
165
|
204
|
219
|
230
|
240
|
|
| Total Equity |
18
N/A
|
31
+75%
|
28
-9%
|
17
-40%
|
21
+26%
|
3
-87%
|
25
+829%
|
12
-53%
|
7
N/A
|
1
+89%
|
|
| Total Liabilities & Equity |
38
N/A
|
54
+40%
|
46
-15%
|
36
-21%
|
41
+13%
|
18
-55%
|
37
+107%
|
27
-29%
|
19
-27%
|
10
-48%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
